REVENUE MEMORANDUM CIRCULAR NO. 83-2022 issued on June 30, 2022 publishes the May 18, 2022 letter from Food and Drug Administration OIC-Director General, Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The List includes certain medicines prescribed for diabetes, hypertension and mental illnesses; deletes certain medicines for cancer and kidney diseases; and corrects the Dosage Form for a medicine for kidney diseases.